Mankind Pharma Limited, founded in 1991, is a prominent pharmaceutical company that specializes in manufacturing and marketing various pharmaceutical formulations in several acute and chronic therapeutic areas, as well as several consumer healthcare products.
In India, the company has a significant presence in a variety of acute and chronic therapeutic fields, such as anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory.
Mankind Pharma’s Product Line
Mankind Pharma offers a broad range of products, like prescription drugs, over-the-counter drugs, and medical devices. The company’s product line includes medicines for cardiovascular diseases, central nervous system disorders, gastroenterology, and anti-infective drugs. Some of the company’s top-selling products include:
- Manforce: A leading brand of condoms
- Aciloc: A medication used to treat acid reflux and stomach ulcers
- Metrogyl: An antibiotic used to treat infections caused by bacteria and parasites
- Zerodol: A pain-relieving medication used to treat acute pain and inflammation
- Pregaba: A medication used to treat nerve pain caused by diabetes and shingles
- Gas-O-Fast: A range of antacid products that help relieve digestive issues
- Prega News: It is a pregnancy detection kit manufactured by Mankind Pharma
Mankind Pharma’s Growth and Expansion
Over the years, Mankind Pharma has expanded its operations to other countries and established its presence in the global pharmaceutical market. The company has a notable presence in the countries like United States, Europe, Asia, Africa, and the Middle East.
Mankind Pharma has also been investing in research and development to develop innovative medicines that cater to the needs of the global market. The company has established research and development centers in India and the United Kingdom, where it focuses on developing novel drug delivery systems, new chemical entities, and biosimilars.
Mankind Pharma’s Awards and Accolades
- The Best of Bharat Awards 2022 by exchange4media 2022
- Silver Medal from the National Awards for Manufacturing Competitiveness Assessment 2021 by International Research Institute for Manufacturing
- Silver Award for Good Health Brand at IHW Awards 2021 in 2021
- Best Condom Brand of the Year award at Sex Brand Awards
- Pharma OTC Company of the Year Award at Pharma Excellence Awards 2018
- Award for Best Design in Healthcare at Healthcare Leadership Awards 2017
- Amity HR Excellence Award for Performance Management at the 8th Global HR Summit in 2011
Competitors of Mankind Pharma
Mankind Pharma faces stiff competition from other leading pharmaceutical companies such as Sun Pharma, Dr. Reddy’s Laboratories, Cipla, and Lupin.
Mankind Pharma IPO Complete Details:
IPO Date | 25 April 2023 to 27 April 2023 |
Issue Type | Fixed Price Issue |
Listing At | BSE & NSE |
Face Value | 1Rs. Per Share |
Price | Rs. 1026 to 1080 |
Lot Size | 13 |
Issue Size | 40,058,844 shares (Rs.4,326.3 Cr) |
Fresh Issue | 40,058,844 shares (Rs.4,326.36 Cr) |
Listing Date | 08 May 2023 |
Mankind Pharma IPO Timetable:
Activity | Date* |
---|---|
Opening Date | 25 April 2023 |
Closing Date | 27 April 2023 |
Allotment | 03 May 2023 |
Initiation of Refunds | 04 May 2023 |
Credit of Shares to Demat Account | 05 May 2023 |
Listing Date | 08 May 2023 |
Company Financial Details:
Period Ended | Assets | Revenue | Profit After Tax | Borrowings | Reserves and Surplus |
---|---|---|---|---|---|
31 March 2020 | 5,073.29 | 5,975.65 | 1,056.15 | 126.92 | 3,436.34 |
31 March 2021 | 6,372.63 | 6,385.38 | 1,293.03 | 234.53 | 4,674.39 |
31 March 2022 | 9,147.74 | 7,977.58 | 1,452.96 | 868.03 | 6,106.06 |
As Of Now, GMP is Around 105 Rupees.
Also, Check Our Web Story On Mankind Pharma IPO: